ICU Medical, Inc. (NASDAQ:ICUI) CEO Vivek Jain Sells 12,000 Shares

ICU Medical, Inc. (NASDAQ:ICUI) CEO Vivek Jain sold 12,000 shares of the firm’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $156.04, for a total transaction of $1,872,480.00. Following the completion of the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $16,320,691.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

ICU Medical Trading Up 0.2 %

Shares of ICU Medical stock opened at $158.44 on Monday. The company has a 50-day moving average of $125.56 and a two-hundred day moving average of $110.25. ICU Medical, Inc. has a 12-month low of $78.28 and a 12-month high of $159.50. The company has a current ratio of 2.61, a quick ratio of 1.09 and a debt-to-equity ratio of 0.76. The stock has a market cap of $3.86 billion, a PE ratio of -64.67 and a beta of 0.69.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.56. The firm had revenue of $596.50 million during the quarter, compared to the consensus estimate of $556.64 million. ICU Medical had a positive return on equity of 5.38% and a negative net margin of 2.63%. ICU Medical’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period last year, the business posted $1.58 EPS. On average, research analysts anticipate that ICU Medical, Inc. will post 3.5 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Motco acquired a new stake in ICU Medical in the 1st quarter valued at about $29,000. Innealta Capital LLC purchased a new stake in shares of ICU Medical in the second quarter valued at about $32,000. GAMMA Investing LLC grew its position in shares of ICU Medical by 75.1% in the first quarter. GAMMA Investing LLC now owns 310 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 133 shares during the last quarter. EntryPoint Capital LLC increased its stake in shares of ICU Medical by 731.5% during the 1st quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier’s stock worth $48,000 after purchasing an additional 395 shares in the last quarter. Finally, CWM LLC increased its stake in shares of ICU Medical by 341.2% during the 4th quarter. CWM LLC now owns 578 shares of the medical instruments supplier’s stock worth $58,000 after purchasing an additional 447 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on ICUI shares. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Thursday, August 8th. Raymond James upped their price objective on ICU Medical from $135.00 to $158.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. Finally, KeyCorp increased their price objective on ICU Medical from $136.00 to $147.00 and gave the stock an “overweight” rating in a research report on Thursday, August 8th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, ICU Medical has a consensus rating of “Moderate Buy” and an average price target of $138.33.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.